Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: a multicenter, randomized, double-blind, placebo-controlled study.

Lambert, Robert G W   •   Salonen, David   •   Rahman, Proton   •   Inman, Robert D   •   Wong, Robert L   •   Einstein, Steven G   •   Thomson, Glen T D   •   Beaulieu, Andre   •   Choquette, Denis   •   Maksymowych, Walter P

published in: Arthritis and rheumatism